SBRT
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
SBRT
Oct 18, 2024, 12:22 |
Insight
Gustavo Viani: PACE-B supports SBRT as a noninferior option for prostate cancer
Gustavo Viani posted the following on LinkedIn: “PACE-B supports SBRT as a noninferior option for…
Oct 14, 2024, 13:28 |
Insight
Gustavo Viani: Prostate SBRT with an integrated focal boost demonstrated excellent 5-year outcomes
Gustavo Viani shared a post on LinkedIn: "Prostate SBRT with an integrated focal boost demonstrated excellent…
Oct 7, 2024, 08:15 |
Insight
Choosing between Stereotactic and Hypofractionated Radiotherapy for inoperable Stage I NSCLC, summarised by Gustavo Viani
Gustavo Viani, Associate Professor, Faculdade de Medicina de Ribeirão Preto (FMRP) da USP, shared a post…
Sep 26, 2024, 14:11 |
Blog
Simul Parikh: With prior authorization, the goal is cost containment
Simul Parikh, Medical Director, OncoHealth, shared a post on LinkedIn: "Invisible Savings" With prior authorization,…
Sep 7, 2024, 09:37 |
Insight
An article for those who worry about single-fraction lung SBRT
Drew Moghanaki shared a post on X: "Here's an article for those who worry about…
Sep 2, 2024, 17:17 |
Insight
Jarushka Naidoo: Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
Jarushka Naidoo shared a post on X: "Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early…
Aug 31, 2024, 17:06 |
Insight
Amir Safavi: How to improve the safety of SABR for ultra central thoracic tumors?
Amir Safavi, Radiation Oncology Fellow at Memorial Sloan Kettering Cancer Centre ,shared a post on…
Aug 26, 2024, 21:18 |
Blog
Drew Moghanaki: The importance of intraop LN sampling
Drew Moghanaki shared on X: “As a lung cancer specialist, I stand by the importance…
Aug 26, 2024, 06:20 |
Blog
SBRT in Prostate Cancer at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "Five-year outcomes from…
Aug 21, 2024, 14:23 |
Blog
STORM trial results at ESTRO 24
ESTRO shared on X: "STORM trial results on the treatment of pelvic nodal oligo-recurrence after…
Aug 17, 2024, 07:54 |
Insight
Leila Tchelebi: Officially in print. Our QA Analysis of Alliance A021501
Leila Tchelebi, Associate Professor of Radiation Medicine at Zucker School of Medicine, shared a post…
Aug 15, 2024, 18:54 |
Blog
ESTRO24 Highlights in radiobiology and SBRT
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "ESTRO24 Highlights in…
Aug 6, 2024, 16:48 |
Insight
Findings from key trials SC.24 and RTOG 0631 and influence SBRT's effectiveness - European Society for Radiotherapy and Oncology
European Society for Radiotherapy and Oncology, shared a post on LinkedIn: "Although some guidelines support…
Jul 25, 2024, 08:21 |
Insight
5-year results of the hypo-FLAME trial on focal boost SBRT for prostate cancer - ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared a post on X: "5-year results of…
Jul 21, 2024, 21:48 |
Blog
Daniel Moore Palhares: The Lancet Oncology editorial on radiosurgery for Celiac plexus pain
Daniel Moore Palhares, Radiation Oncology Fellow at Sunnybrook Health Sciences Centre posted on X about his…
Jul 15, 2024, 14:04 |
Insight
Drew Moghanaki: RCT for oligoprogressive stage IV cancer leveraging “pulsed” SBRT
Drew Moghanaki shared on X: "NEW: phase II randomized clinical trial for oligoprogressive stage IV…
Jul 10, 2024, 06:47 |
Insight
The latest results from the PACE-C trial presented at ESTRO24
ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: . "Check out…
Jun 19, 2024, 03:11 |
Insight
Andres Rodriguez Mignola: SBRT in Oligometastatic Disease in Gynecologic Tumors - A Therapeutic Option?
Andres Rodriguez Mignola, Radiation Oncologist at Ángel Roffo Institute of Oncology, shared a post on…
Jun 10, 2024, 12:19 |
Insight
Results from the TRAP trial presented at ESTRO24
ESTRO shared on X/Twitter: "Results from the TRAP trial presented at ESTRO24: this phase-II trial explores…
May 19, 2024, 17:14 |
Blog
Nina Niu Sanford: Michael Chuong has studied/published on almost everything pancreas SBRT
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a…
May 13, 2024, 10:45 |
Blog
Matt Spraker: I'm giving this radiation oncology talk to demonstrate the value of RT in sarcoma care
Matt Spraker, Radiation Oncologist at the University of Washington, shared a post by Suzie Siegel, Board…
May 8, 2024, 02:11 |
Blog
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "RADIOSA trial: oligorecurrent…
Apr 22, 2024, 17:39 |
Career
Christelle Bouchart: Doctoral thesis done!
Christelle Bouchart, Member of EORTC Young Investigator, shared on LinkedIn: “Doctoral thesis: done! A big…
Apr 7, 2024, 03:13 |
Insight
Harry Nguyen: Most of IR literature in this space was retrospective until DOSIPHERE and the incorporation of personalized dosimetry
Harry Nguyen, Assistant Professor at UCI Health Physicians, recently shared a post by Krishan Jethwa,…
Feb 15, 2024, 12:32 |
Insight
Drew Moghanaki: The importance of more than 110% hotspots in lung SBRT plans
Drew Moghanaki, Professor, Chief of Thoracic Oncology Service at David Geffen School of Medicine at…
Feb 12, 2024, 17:11 |
Blog
Laura Dawson: The SBRT debate was a wonderful way to end the HCC-LIVE Conference
Laura Dawson, Professor & Chair Department Radiation Oncology at the University of Toronto, shared the…
Jan 8, 2024, 14:21 |
Blog
Drew Moghanaki shared a study from Duke University on Stage I NSCLC
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Dec 26, 2023, 13:39 |
Blog
Stefano Arcangeli: The most cost-effective, time sparing and harmless way for prostate SBRT
Stefano Arcangeli, Associate Professor University of Milan Bicocca, shared a post on X/Twitter by Denis Panizza,…
All:
28
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube